Presurance Holdings, Inc. 8-K

What Happened
Presurance Holdings, Inc. (PRHI) announced in an 8-K that on March 3, 2026 it received a Notice from the Nasdaq Listing Qualifications Staff saying the closing bid price of its common stock was below the $1.00 minimum required by Nasdaq Rule 5550(a)(2). Under Nasdaq Rule 5810(c)(3)(A) the company has 180 calendar days from March 3, 2026 (until August 31, 2026) to regain compliance by achieving a $1.00 closing bid for at least 10 consecutive business days. If compliance is not regained, Nasdaq may grant an additional 180-day cure period only if the company meets other initial listing standards (except the minimum bid price) and provides written notice of its intent to cure.

Key Details

• Notice date: March 3, 2026; 180-day compliance period ends August 31, 2026.
• Compliance condition: closing bid ≥ $1.00 for a minimum of 10 consecutive business days (number of days may be extended by Nasdaq).
• Reverse split authorization: shareholders approved June 2025 a reverse stock split range of 1-for-2 to 1-for-12; the board may select a ratio up to June 3, 2026 and may implement a split if deemed in shareholders’ best interests.
• If Nasdaq determines the company cannot cure the deficiency or is ineligible for relief, Nasdaq may move to delist; the company would have the right to appeal to a Nasdaq hearings panel.

Why It Matters
A failure to regain compliance could lead to delisting, which typically reduces a stock’s liquidity and makes trading and access for investors more difficult. The company is monitoring options (including a possible reverse stock split that would likely raise the per‑share price) but has not yet decided to implement one. There is no assurance the company will regain compliance within the initial 180 days, obtain a second cure period, or otherwise avoid future Nasdaq listing actions—investors should be aware of the heightened listing risk and potential impacts on trading liquidity.